Christine M. Toedebusch
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (20)
Background/Objectives: Spondylocostal dysostosis (SCDO) is a rare disorder characterized by congenital malformations of the spine and ribs. SCDO affects 1 in 40,000 human births, with rare cases also reported in dogs. Mutations in DLL3, encoding a critical Notch signaling pathway ligand, account for a majority of human SCDO cases. The remaining cases have variants in HES7, LFNG, MESP2, RIPPLY2, TBX6, and DLL1, which code for proteins in the Notch pathway. A mixed-breed litter of three dogs presented with varying degrees of spinal malformations and underwent comprehensive phenotyping including radiographic and neurologic examination. Two littermates demonstrated classic SCDO features including shortened torsos, vertebral malformations, and rib abnormalities, while a third showed only caudal vertebral truncation. Methods: Short-read whole-genome sequencing was performed on all three animals, followed by variant filtering and analysis using the two severely affected dogs as cases and 173 control dogs of various breeds. Variants were prioritized based on segregation patterns, population frequency, and predicted functional impact using established bioinformatics tools. Results: Variant analysis identified a novel splice acceptor variant in DLL3 (c.650-2A>C). This mutation, located at the splice acceptor site preceding exon 5, is predicted to disrupt critical EGF-like domains and O-fucosylation sites essential for DLL3 protein function. Conclusions: This study identifies a DLL3 splice variant causing SCDO in dogs, demonstrating phenotypic conservation with humans. These findings refine our understanding of genotype–phenotype correlations and demonstrate the value of comparative genomics for rare developmental disorders.
Year:
2026
Supplementary Fig. 6. WHO grade 3 meningioma immunofluorescence microscopy for NOTCH3 and the mural cell marker SMA. NOTCH3 is expressed in and out of the perivascular niche, and colocalizes with mural cells in the perivascular niche, in meningiomas with WHO grade 3 histology. SF numbers indicate individual meningiomas. Representative of n=10 WHO grade 3 meningiomas. WHO grade defined using histological criteria. Scale bars, 10µm.
Year:
2024
Supplementary Table S1. Cell cluster marker genes from single-cell RNA sequencing of human meningiomas with loss of chromosome 22q. Supplementary Table S2. Cell cluster marker genes from single-cell RNA sequencing of dog meningiomas. Supplementary Table S3. RNA sequencing differential expression analyses across recurrent versus primary human meningiomas. Supplementary Table S4. Antibodies for multiplexed sequential immunofluorescence. Supplementary Table S5. Cell cluster marker genes from single-cell RNA sequencing of human cells from meningioma xenografts. Supplementary Table S6. Cell cluster marker genes from single-cell RNA sequencing of mouse cells from meningioma xenografts.
Year:
2024
Supplementary Fig. 5. WHO grade 2 meningioma immunofluorescence microscopy for NOTCH3 and the mural cell marker SMA. NOTCH3 expression is primarily restricted to the perivascular niche and colocalizes with mural cells in meningiomas with WHO grade 2 histology. SF numbers indicate individual meningiomas. WHO grade defined using histological criteria. Representative of n=10 WHO grade 2 meningiomas. Scale bars, 10µm.
Year:
2024
Supplementary Fig. 4. WHO grade 1 meningioma immunofluorescence microscopy for NOTCH3 and the mural cell marker SMA. NOTCH3 expression is restricted to the perivascular niche and colocalizes with mural cells in meningiomas with WHO grade 1 histology. SF numbers indicate individual meningiomas. WHO grade defined using histological criteria. Representative of n=10 WHO grade 1 meningiomas. Scale bars, 10µm.
Year:
2024
Supplementary Fig. 13. Analysis of human and mouse cell types from single-cell RNA sequencing of meningioma xenografts. A, Feature plots showing differentially expressed genes across UMAP clusters from CH-157MN meningioma xenograft human cells analyzed using single-cell RNA sequencing. See also Supplementary Table 5. B, Meningioma xenograft human single-cell cluster changes across experimental conditions and biological replicates. Student’s t -tests. C, Single-cell RNA sequencing UMAP of 34,902 meningioma xenograft mouse cell transcriptomes showing microenvironment cell types. D, Feature plots showing differentially expressed genes across UMAP clusters from meningioma xenograft mouse cells analyzed using single-cell RNA sequencing. E, Meningioma xenograft mouse single-cell cluster changes across experimental conditions and biological replicates. See also Supplementary Table 6. Student’s t tests.
Year:
2024
Supplementary Fig. 11. Ptgds is expressed throughout the meninges. Confocal microscopy of whole mount mouse convexity meningeal samples at P7, P30, or P90 after recombination of the ROSAmT/mG allele using Ptgds-Cre shows PTGDS cells are diffusely expressed throughout perivascular and non-perivascular meningeal cells. DAPI marks DNA. Representative of n=3 biological replicates per timepoint. Scale bar, 100µm.
Year:
2024
Supplementary Fig. 9. WHO grade 3 meningioma immunofluorescence microscopy for NOTCH3 and the endothelial cell marker VWF. NOTCH3 is expressed in and out of the perivascular niche, and is adjacent to endothelial cells in the perivascular niche, in meningiomas with WHO grade 3 histology. SF numbers indicate individual meningiomas. Representative of n=10 WHO grade 3 meningiomas. WHO grade defined using histological criteria. Scale bars, 10µm.
Year:
2024
Supplementary Fig. 7. WHO grade 1 meningioma immunofluorescence microscopy for NOTCH3 and the endothelial cell marker VWF. NOTCH3 expression is restricted to the perivascular niche adjacent to endothelial cells in meningiomas with WHO grade 1 histology. SF numbers indicate individual meningiomas. Representative of n=10 WHO grade 1 meningiomas. WHO grade defined using histological criteria. Scale bars, 10µm.
Year:
2024
Supplementary Fig. 15. NOTCH3 RNAScope across meningioma DNA methylation groups. RNAScope for NOTCH3 and NF2 integrated with IF for the endothelial cell marker VE-cadherin in meningiomas with paired DNA methylation profiling and targeted next-generation DNA sequencing reveals NOTCH3 expression is enriched in meningiomas with biallelic NF2 inactivation from DNA methylation groups with adverse clinical outcomes. Both Hypermitotic meningiomas analyzed were recurrent after prior surgery and radiotherapy. WHO grade defined using histological criteria. Scale bar, 10µm.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (16)
Aparna Bhaduri
Assistant Professor
University of California, Los Angeles
Brisa Palikuqi
Assistant Professor
Yale University
Craig Horbinski
Northwestern University
Peter J. Dickinson
-
Ophir Klein
Cedars-Sinai Medical Center
Alan Ashworth
University of California, San Francisco
Shawn L. Hervey‐Jumper
Professor
University of California, San Francisco
Stephen T. Magill
Assistant Professor
Northwestern University
Amy B. Heimberger
Professor
Northwestern University
Calixto-Hope G Lucas
Johns Hopkins University School of Medicine
Arie Perry
University of California, San Francisco
David R Raleigh
University of California, San Francisco
Joanna J. Phillips
Profesor
University of California, San Francisco
Karen Vernau
Clinical Professor of Neurology/Neurosurgery
University of California, Davis
Danika Bannasch
Professor
University of California, Davis
Kevin Woolard
Assistant Professor of Veterinary Anatomic Pathology
University of California, Davis
Make your next move.
Prepare your application
Review drafts before you send them.